2025
SJR Q1
JCR Q1 · 4,9
36 matched articles
SCIE
Journal detail
Molecular Pharmaceutics
- Publisher
- American Chemical Society
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1543838415438392
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,957
- Quartile Q1
- H-Index 172
- Cites/doc 4,86
- Docs (3y) 1.434
- Cites (3y) 7.218
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,9
- 5Y JIF 5,1
- JCI 1,16
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Drug Discovery Q2
- Molecular Medicine Q2
- Pharmaceutical Science Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Medicine, Research & Experimental | Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 0,957 | 4,9 | 5,1 | 1,16 | Q1 | 172 |
| 2024 | Q1 | Q1 | 0,968 | 4,5 | 4,7 | 1,24 | Q1 | 163 |
| 2023 | Q1 | Q1 | 0,94 | 4,5 | 4,6 | 1,22 | Q1 | 163 |
| 2022 | Q1 | Q1 | 0,929 | 4,9 | 5 | 1,3 | Q1 | 163 |
| 2021 | Q1 | Q1 | 0,936 | 5,4 | 5,4 | 1,33 | Q1 | 163 |
| 2020 | Q1 | Q1 | 1,13 | 4,9 | 5,1 | 1,46 | Q1 | 163 |
| 2019 | Q1 | Q1 | 1,213 | 4,3 | 4,5 | 1,63 | Q1 | 163 |
| 2018 | — | Q1 | — | 4,4 | 4,7 | 1,77 | Q1 | — |
| 2017 | Q1 | Q1 | 1,572 | 4,6 | 4,8 | 1,82 | Q1 | 163 |
| 2016 | Q1 | Q1 | 1,538 | 4,4 | 4,7 | — | — | 163 |
| 2015 | Q1 | Q1 | 1,605 | 4,3 | 4,7 | — | — | 163 |
| 2014 | Q1 | Q1 | 1,641 | 4,4 | 5 | — | — | 163 |
| 2013 | Q1 | Q1 | 1,903 | 4,8 | 5,6 | — | — | 163 |
| 2012 | Q1 | Q1 | 2,152 | 4,6 | 5,8 | — | — | 163 |
| 2011 | Q1 | Q1 | 2,351 | 4,8 | 5,6 | — | — | 163 |
| 2010 | Q1 | Q1 | 2,252 | 5,4 | 5,8 | — | — | 163 |
| 2009 | — | Q1 | — | 5,4 | 5,2 | — | — | — |
| 2008 | — | Q1 | — | 4,6 | 4,4 | — | — | — |
| 2007 | — | Q1 | — | 3,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 52/191 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 74/356 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 52/195 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 64/352 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 52/189 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 60/354 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 52/136 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 61/278 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 51/139 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 65/279 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 51/140 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 69/276 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 39/139 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 48/271 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 36/136 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 39/267 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 24/133 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 27/261 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 21/128 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 32/257 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 22/124 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 38/255 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 22/123 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 29/255 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 16/124 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 24/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 30/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 27/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 17/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 16/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 24/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 47/205 |